Patrick Forsythe
Patrick Forsythe is the vice-president and general manager in Canada for Eisai, the pharmaceutical company that co-developed the Alzheimer's drug lecanemab, which has recently been approved by Health Canada. He expressed optimism about the drug's long-awaited approval, marking a significant advancement in Alzheimer's treatment.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Patrick Forsythe is the vice-president and general manager in Canada for Eisai, which co-developed the drug with Biogen Inc.
7